Fred Alger Management, LLC Gossamer Bio, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $240,000 - $464,400	-30,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.02 - $22.47 $320,400 - $449,400	-20,000 Reduced 40.0%	30,000 $504,000
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $80,600 - $114,450	-5,000 Reduced 9.09%	50,000 $1.11 Million
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $966,899 - $1.32 Million	55,000 New	55,000 $1.19 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.